Condition
Methamphetamine-dependence clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Methamphetamine-dependence clinical trials that are recruiting, at sites in 3 countries (most in United States (3), Canada (2), Germany (1)). By phase: Phase 2 (3), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest Methamphetamine-dependence clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Glutide for Ending Methamphetamine | Phase 2 | San Francisco, California | Recruiting | Oct 2, 2025 |
| Long-term high-dose lisdexamfetamine treatment for methamphetamine use disorder | Phase 2 | Montreal, Quebec | Recruiting | Jan 23, 2025 |
| Investigating how Pavlovian mechanisms influence substance use behaviors | — | Dresden | Recruiting | Nov 22, 2024 |
| High dose stimulant treatment for methamphetamine users | Phase 2 | Vancouver, British Columbia and 3 other locations | Recruiting | May 11, 2023 |
| Using brain stimulation to reduce cravings in methamphetamine users | — | Portland, Oregon | Recruiting | Mar 20, 2018 |
| Using creatine to help treat depression in methamphetamine users | Phase 3 | Missoula, Montana | Recruiting | Oct 6, 2015 |
All recruiting trials (6)
-
Glutide for Ending Methamphetamine
This study tests Wegovy (semaglutide) to see if it can help people with methamphetamine use disorder reduce use or stop using it.
-
Long-term high-dose lisdexamfetamine treatment for methamphetamine use disorder
This trial will try giving adults with moderate to severe methamphetamine use disorder a 25-week course of high-dose lisdexamfetamine plus their usual care to see if it helps them stay in treatment and cut down on methamphetamine use compared with placebo.
-
Investigating how Pavlovian mechanisms influence substance use behaviors
This study is testing how certain learned responses might affect substance use behaviors in people with moderate to severe substance use disorders compared to healthy individuals.
-
High dose stimulant treatment for methamphetamine users
This study is testing whether a high dose of a medication called lisdexamfetamine, along with support and rewards, can help adults who use methamphetamine reduce their drug use more effectively than standard treatment alone.
-
Using brain stimulation to reduce cravings in methamphetamine users
This study tests whether a type of brain stimulation can help reduce cravings for methamphetamine in adults who are trying to stay off the drug.
-
Using creatine to help treat depression in methamphetamine users
This study is testing if creatine can help reduce depression and anxiety in people who are dependent on methamphetamine.
Related topics
Quick answers
How many Methamphetamine-dependence clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), Canada (2 trials), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.